Life sciences news
-
Biotalys awarded €1.1 million VLAIO research grant
Thursday October 1st 2020
Read more
-
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
Wednesday September 30th 2020
Read more
-
Biocartis receives EUR 1.2 million grant for development of highly innovative Idylla™ GeneFusion Assay
Wednesday September 30th 2020
Read more
-
BISC Global selected as top 10 bioinformatics company by CIO Applications
Tuesday September 29th 2020
Read more
-
Celyad Oncology announces clinical trial collaboration to evaluate CYAD-101 with KEYTRUDA® (pembrolizumab) in patients with Microsatellite Stable mCRC
Tuesday September 29th 2020
Read more
-
Jyseleca® (filgotinib) approved by European Commission for rheumatoid arthritis
Friday September 25th 2020
Read more
-
Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
Friday September 25th 2020
Read more
-
Bioqube Ventures welcomes two seasoned professionals
Friday September 25th 2020
Read more
-
Become a flanders.bio member
Your news here?
-
Johnson & Johnson initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 vaccine candidate
Thursday September 24th 2020
Read more
-
Camel-IDS enters next stage with name change to PRECIRIX® and IND approval for CAM-H2 Phase I/II study
Tuesday September 22nd 2020
Read more
-
Handl Therapeutics awarded a €3 million research grant by Flanders Innovation & Entrepreneurship (VLAIO)
Tuesday September 15th 2020
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
